Cannabis Bioscience International Holdings (CBIH) Operating Expenses (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Operating Expenses across 5 years of filings, most recently posting $101419.0 for Q1 2026.

• Operating Expenses for Q1 2026 came in at $101419.0, down 18.71% year-over-year; the trailing twelve-month figure through Feb 2026 was $496214.0 (down 19.26% YoY), and the FY2025 annual result was $684281.0, down 0.74% from the prior year.
• Operating Expenses came in at $101419.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from $138643.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $311998.0 in Q1 2023 to a low of $90841.0 in Q3 2025.
• The 5-year median for Operating Expenses is $154239.5 (2023), against an average of $182552.0.
• Across the five-year window, Operating Expenses slumped 68.68% in 2024 and surged 72.89% in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Operating Expenses stood at $259099.0 in 2022, then sank by 44.74% to $143168.0 in 2023, then slipped by 11.94% to $126072.0 in 2024, then rose by 9.97% to $138643.0 in 2025, then dropped by 26.85% to $101419.0 in 2026.
• The last three Operating Expenses figures came in at $101419.0 (Q1 2026), $138643.0 (Q4 2025), and $90841.0 (Q3 2025), per Business Quant data.